Young people who used their smartphone five or more hours per day were 43% more likely to be obese than their counterparts with less reported screen time in a recent study presented at the ACC Latin American Conference 2019 in Cartagena, Colombia.

The Cardiovascular Research Foundation is partnering with VEITHsymposium, one of the largest annual meetings in vascular medicine, to enhance conference material at both VEITHsymposium and the CRF’s yearly Transcatheter Cardiovascular Therapeutics conference, the groups announced June 20.

A novel robotic catheter could simplify valve procedures while allowing cardiac surgeons to complete multiple interventions within the same time frame, according to research presented at TVT 2019 in Chicago.

Inadequate fruit and vegetable consumption contributes to nearly 2 million CV-related deaths each year, according to research presented at Nutrition 2019, the American Society for Nutrition’s annual meeting, in Baltimore.

Research presented at TVT 2019 in Chicago last week suggests a transcarotid approach to transcatheter aortic valve replacement is favorable for patients unable to tolerate femoral access, topping both transapical and transaortic approaches as the preferable route for alternate-access TAVR.  

Physicians are facing a new issue as TAVR expands to younger populations—an increased incidence of bicuspid aortic stenosis.

The undertreatment of aortic stenosis in the U.S. is severe, driven by deep-rooted racial and sex disparities and a disconnect between patients and their clinicians.

The so-called “weekend effect”—that idea that patients admitted to the hospital on Saturdays, Sundays and holidays face greater odds of readmission down the line—doesn’t apply to victims of cardiac arrest, according to data presented at the British Cardiovascular Society Conference in Manchester June 2.

Loneliness, above all else, was an independent predictor of whether patients stuck to their doctors’ guidelines.

The risk of peripartum cardiomyopathy (PPCM) is up to five times higher in mothers who undergo common fertility treatments like intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF), according to data presented at Heart Failure 2019 in Athens.

Results from the TRILUMINATE study, presented this week at EuroPCR 2019 in Paris, suggest Abbott’s minimally invasive tricuspid valve repair system is an effective solution for patients with structural heart disease, reducing the severity of tricuspid regurgitation (TR) in more than 85% of test cases.

A trio of studies presented at the Heart Rhythm Society’s 40th annual scientific sessions earlier this month highlight significant disparities in patient access to implantable cardiac devices—particularly in women and black patients.